These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Actions of dopaminergic agonists on motor function. Costall B; Naylor RJ Adv Neurol; 1975; 9():285-97. PubMed ID: 1170715 [No Abstract] [Full Text] [Related]
5. The effects of dopaminergic agonists on genital reflexes in paradoxical sleep-deprived male rats. Andersen ML; Tufik S Physiol Behav; 2005 Feb; 84(2):205-10. PubMed ID: 15708772 [TBL] [Abstract][Full Text] [Related]
6. Sedative action of low doses of dopaminergic agents. Maj J; Przewlocka B; Kukulka L Pol J Pharmacol Pharm; 1977; 29(1):11-21. PubMed ID: 857245 [TBL] [Abstract][Full Text] [Related]
7. Apomorphine and piribedil in rats: biochemical and pharmacologic studies. Butterworth RF; Poignant JC; Barbeau A Adv Neurol; 1975; 9():307-26. PubMed ID: 1170716 [TBL] [Abstract][Full Text] [Related]
9. Effect of chronic levodopa on haloperidol-induced behavioral supersensitivity in the guinea pig. Weiner WJ; Carvey P; Nausieda PA; Goetz CG; Klawans HL Adv Neurol; 1982; 35():213-9. PubMed ID: 6890754 [No Abstract] [Full Text] [Related]
10. [Possibilities for behavior correction in a learned ethanol preference in female and male white rats]. Andronova LM Farmakol Toksikol; 1987; 50(4):55-60. PubMed ID: 3666118 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of apomorphine-induced inhibition of vocalisation afterdischarge response by theophylline. Paalzow G; Paalzow L Life Sci; 1975 Oct; 17(7):1145-51. PubMed ID: 1196004 [No Abstract] [Full Text] [Related]
12. Proposal of a new model with dopaminergic-cholinergic interactions for neuropharmacological investigations. Carolei A; Margotta V; Palladini G Neuropsychobiology; 1975; 1(6):355-64. PubMed ID: 185543 [TBL] [Abstract][Full Text] [Related]
13. Myoclonus induced by intermittent light stimulation in the baboon: neurophysiological and neuropharmacological approaches. Naquet R; Meldrum BS Adv Neurol; 1986; 43():611-27. PubMed ID: 3946120 [No Abstract] [Full Text] [Related]
15. Experimental aggression and bruxism in rats. Pohto P Acta Odontol Scand; 1979; 37(2):117-26. PubMed ID: 220835 [TBL] [Abstract][Full Text] [Related]
16. [Comparison of certain central effects of atropine, scopolamine and their quaternary ammonium derivatives in animals]. Malatray J; Simon P Therapie; 1972; 27(1):153-66. PubMed ID: 5017551 [No Abstract] [Full Text] [Related]
17. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroing" and "agitation" in rats. Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM Arzneimittelforschung; 1967 Jul; 17(7):841-54. PubMed ID: 5632842 [No Abstract] [Full Text] [Related]
18. Comparative effects of the dopaminergic agonists piribedil and bromocriptine in three different memory paradigms in rodents. Marighetto A; Valerio S; Philippin JN; Bertaina-Anglade V; Drieu la Rochelle C; Jaffard R; Morain P J Psychopharmacol; 2008 Jul; 22(5):511-21. PubMed ID: 18308794 [TBL] [Abstract][Full Text] [Related]
19. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors. Brocco M; Dekeyne A; Papp M; Millan MJ Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological difference of L-dopa, apomorphine, and bromocriptine against metoclopramide. Fang VS Life Sci; 1981 May; 28(19):2143-9. PubMed ID: 7253807 [No Abstract] [Full Text] [Related] [Next] [New Search]